Blue Note Therapeutics develops prescription digital therapeutics that utilize evidence-based behavioral interventions to improve patient outcomes in mental health. The company targets the challenges of treatment adherence and access to care by providing scalable, clinically validated solutions for patients managing mental health conditions.
Funding
$41.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients managing mental health conditions often struggle with treatment adherence and limited access to care, hindering optimal outcomes. Traditional therapeutic interventions may not be scalable or readily available to all who need them.
Solution
Blue Note Therapeutics develops prescription digital therapeutics that leverage evidence-based behavioral interventions to improve mental health outcomes. By delivering clinically validated treatments through digital platforms, the company aims to address the challenges of treatment adherence and expand access to care. These digital therapeutics provide scalable solutions for patients managing various mental health conditions, potentially enhancing engagement and improving overall well-being. The company focuses on creating accessible and convenient therapeutic options.
Target Audience
The primary target audience includes patients managing mental health conditions, as well as healthcare providers seeking scalable and accessible treatment options.
Features
- Prescription-based digital therapeutics for mental health conditions
- Utilizes evidence-based behavioral interventions
- Scalable platform for broad patient reach
- Aims to improve treatment adherence
- Clinically validated solutions